Skip to main content
Rheumatology and Therapy logoLink to Rheumatology and Therapy
. 2022 Sep 5;9(5):1475–1476. doi: 10.1007/s40744-022-00479-0

Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry

Manuel José Moreno-Ramos 1, Carlos Sanchez-Piedra 2, Olga Martínez-González 3, Carlos Rodríguez-Lozano 4, Carolina Pérez-Garcia 5, Mercedes Freire 6, Cristina Campos 7, Rafael Cáliz-Caliz 8, Jerusalem Calvo 9, Juan María Blanco-Madrigal 10, Ana Pérez-Gómez 11, María José Moreno-Martínez 12,✉, Luis Linares 1, Fernando Sánchez-Alonso 2, Carlos Sastré 13, Isabel Castrejón 14
PMCID: PMC9510073  PMID: 36063343

Correction to: Rheumatol Ther (2022) 9:1031–1047 10.1007/s40744-022-00446-9

In the original article entitled "Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry", the legend for Supplementary Fig. 2B included a typo in the colors. The legend for Supplementary Fig. 2B should have appeared as shown below:graphic file with name 40744_2022_479_Figa_HTML.jpg

In addition, the order of the colors and items in the legends of Supplementary Figs. 4 and 5B has been modified.

The wrong Supplementary file that was originally published with this article has now been replaced with the correct file.


Articles from Rheumatology and Therapy are provided here courtesy of Springer

RESOURCES